Wire · operational-macro
Biostream Urine Test Declared FDA Breakthrough Device
◆ Sectors
Diagnostics
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 20 November 2026 · Fusion42 review
The FDA has granted breakthrough device designation to Biostream's investigational urine test for idiopathic normal pressure hydrocephalus, recognising its potential to address a significant unmet medical need.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it.
◆ ◆ The Wire takeaway
The FDA's nod opens a faster route to market for you if you're developing diagnostics for neurological disorders. This status can boost investor and partner interest immediately.
◆ Coverage
2 sources · 20 Nov 2026
◆ Related on Wire
◆ Topics
Diagnosticsfdabreakthrough-devicediagnosticsurine-testhydrocephalus